Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Lupus nephritis
•
Systemic lupus erythematosus
•
Nephrology
Where do you introduce SGLT2 and GLP1 medications in the sequence of treatments for patients with lupus nephritis?
Related Questions
What do you feel are the potential barriers to widespread use of obinutuzumab in proliferative lupus nephritis?
What steroid regimen do you typically use for induction therapy in patients with lupus nephritis?
What factors do you consider when advising a patient with lupus nephritis on the safety of becoming pregnant?
Should HCQ be continued in an asymptomatic SLE patient who has received renal transplant?
How would you approach a patient with class III and V lupus nephritis, already on HCQ, MMF, voclosporin and losartan, but has continued proteinuria not yet attaining complete renal response?
In patients with lupus nephritis, and MAHA with positive anti-phospholipid autoantibodies, what are the considerations to use or not use anti-coagulation therapy?
How do you approach the management of patients with suspected membranous lupus nephritis who are found to have positive PLA2R antibodies?
What are some practical tips for tacrolimus management/monitoring in SLE nephritis?
How do you treat a patient with new class V lupus nephritis and recent hx of breast cancer on tamoxifen?
How would you approach a patient with SLE and stage 4 LN who presents with persistent significant elevation in ESR, CRP and dsDNA despite improvement of symptoms and resolution of proteinuria on MMF and HCQ?
